Cannabidiol prevents LPS‐induced microglial inflammation by inhibiting ROS/NF‐κB‐dependent signaling and glucose consumption
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cannabidiol prevents LPS‐induced microglial inflammation by inhibiting ROS/NF‐κB‐dependent signaling and glucose consumption
Authors
Keywords
-
Journal
GLIA
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-10-25
DOI
10.1002/glia.23738
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Glucose transporter 1 critically controls microglial activation through facilitating glycolysis
- (2019) Luxi Wang et al. Molecular Neurodegeneration
- Acute glucose fluctuation impacts microglial activity, leading to inflammatory activation or self-degradation
- (2019) Cheng-Fang Hsieh et al. Scientific Reports
- Nerve Growth Factor modulates LPS - induced microglial glycolysis and inflammatory responses
- (2019) Georgia Fodelianaki et al. EXPERIMENTAL CELL RESEARCH
- Cannabidiol protects livers against nonalcoholic steatohepatitis induced by high‐fat high cholesterol diet via regulating NF‐κB and NLRP3 inflammasome pathway
- (2019) Yuanling Huang et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Use of Cannabidiol in the Treatment of Epilepsy: Efficacy and Security in Clinical Trials
- (2019) Serena Silvestro et al. MOLECULES
- Parkin deficiency modulates NLRP3 inflammasome activation by attenuating an A20-dependent negative feedback loop
- (2018) François Mouton-Liger et al. GLIA
- Cannabinoid CB2 receptors in the mouse brain: relevance for Alzheimer’s disease
- (2018) Alicia López et al. Journal of Neuroinflammation
- Cannabinoid Delivery Systems for Pain and Inflammation Treatment
- (2018) Natascia Bruni et al. MOLECULES
- Cannabidiol Attenuates Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis Through Induction of Myeloid-Derived Suppressor Cells
- (2018) David M. Elliott et al. Frontiers in Immunology
- Cannabidiol reduces airway inflammation and fibrosis in experimental allergic asthma
- (2018) Francieli Vuolo et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Microglial glutamate release evoked by α-synuclein aggregates is prevented by dopamine
- (2018) Mauricio dos-Santos-Pereira et al. GLIA
- Anti-neuroinflammatory effects of GPR55 antagonists in LPS-activated primary microglial cells
- (2018) Soraya Wilke Saliba et al. Journal of Neuroinflammation
- Neuroprotection by cannabidiol and hypothermia in a piglet model of newborn hypoxic-ischemic brain damage
- (2018) Lorena Barata et al. NEUROPHARMACOLOGY
- A presumed antagonistic LPS identifies distinct functional organization of TLR4 in mouse microglia
- (2017) Christin Döring et al. GLIA
- Bioenergetic regulation of microglia
- (2017) Soumitra Ghosh et al. GLIA
- Inflammasomes and IL-1 biology in the pathogenesis of allograft dysfunction
- (2017) S. Samuel Weigt et al. JOURNAL OF CLINICAL INVESTIGATION
- An update on PPAR activation by cannabinoids
- (2016) Saoirse Elizabeth O'Sullivan BRITISH JOURNAL OF PHARMACOLOGY
- A simplified approach for efficient isolation of functional microglial cells: Application for modeling neuroinflammatory responsesin vitro
- (2016) Julia E. Sepulveda-Diaz et al. GLIA
- Cannabidiol Limits T Cell-Mediated Chronic Autoimmune Myocarditis: Implications to Autoimmune Disorders and Organ Transplantation
- (2016) Wen-Shin Lee et al. MOLECULAR MEDICINE
- Co-administration of cannabidiol and capsazepine reduces L-DOPA-induced dyskinesia in mice: Possible mechanism of action
- (2016) Maurício dos-Santos-Pereira et al. NEUROBIOLOGY OF DISEASE
- Cannabidiol, neuroprotection and neuropsychiatric disorders
- (2016) Alline C. Campos et al. PHARMACOLOGICAL RESEARCH
- From Phytocannabinoids to Cannabinoid Receptors and Endocannabinoids: Pleiotropic Physiological and Pathological Roles Through Complex Pharmacology
- (2016) Alessia Ligresti et al. PHYSIOLOGICAL REVIEWS
- Microglial M1/M2 polarization and metabolic states
- (2015) Ruben Orihuela et al. BRITISH JOURNAL OF PHARMACOLOGY
- Are cannabidiol and Δ9-tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review
- (2015) John M McPartland et al. BRITISH JOURNAL OF PHARMACOLOGY
- Unknown
- (2015) Enkui Hao et al. MOLECULAR MEDICINE
- Lactate is always the end product of glycolysis
- (2015) Matthew J. Rogatzki et al. Frontiers in Neuroscience
- System xC− is a mediator of microglial function and its deletion slows symptoms in amyotrophic lateral sclerosis mice
- (2014) Pinar Mesci et al. BRAIN
- Antidepressant-Like and Anxiolytic-Like Effects of Cannabidiol: A Chemical Compound of Cannabis sativa
- (2014) Alexandre Schier et al. CNS & Neurological Disorders-Drug Targets
- Glucose pathways adaptation supports acquisition of activated microglia phenotype
- (2014) J. Gimeno-Bayón et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Evaluation of the insulin releasing and antihyperglycaemic activities of GPR55 lipid agonists using clonal beta-cells, isolated pancreatic islets and mice
- (2013) A M McKillop et al. BRITISH JOURNAL OF PHARMACOLOGY
- Inflammatory response of microglial BV-2 cells includes a glycolytic shift and is modulated by mitochondrial glucose-regulated protein 75/mortalin
- (2013) Ludmila A. Voloboueva et al. FEBS LETTERS
- Understanding the Molecular Aspects of Tetrahydrocannabinol and Cannabidiol as Antioxidants
- (2013) Rosivaldo Borges et al. MOLECULES
- Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: A role for A2A receptors
- (2013) M. Mecha et al. NEUROBIOLOGY OF DISEASE
- Direct modulation of the outer mitochondrial membrane channel, voltage-dependent anion channel 1 (VDAC1) by cannabidiol: a novel mechanism for cannabinoid-induced cell death
- (2013) N Rimmerman et al. Cell Death & Disease
- Is the cardiovascular system a therapeutic target for cannabidiol?
- (2012) Christopher P. Stanley et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Off-Target Cannabinoid Effects Mediated by GPR55
- (2012) Christopher M. Henstridge PHARMACOLOGY
- Cannabidiol inhibits pathogenic T cells, decreases spinal microglial activation and ameliorates multiple sclerosis-like disease in C57BL/6 mice
- (2011) Ewa Kozela et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabidiol and Other Cannabinoids Reduce Microglial Activation In Vitro and In Vivo: Relevance to Alzheimer's Disease
- (2011) A. M. Martin-Moreno et al. MOLECULAR PHARMACOLOGY
- Cannabidiol Reduces Aβ-Induced Neuroinflammation and Promotes Hippocampal Neurogenesis through PPARγ Involvement
- (2011) Giuseppe Esposito et al. PLoS One
- Plasma and brain pharmacokinetic profile of cannabidiol (CBD), cannabidivarine (CBDV), Δ9-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessive–compulsive behaviour
- (2011) Serena Deiana et al. PSYCHOPHARMACOLOGY
- Pathways mediating the effects of cannabidiol on the reduction of breast cancer cell proliferation, invasion, and metastasis
- (2010) Sean D. McAllister et al. BREAST CANCER RESEARCH AND TREATMENT
- CB1 and CB2 cannabinoid receptor expression during development and in epileptogenic developmental pathologies
- (2010) E. Zurolo et al. NEUROSCIENCE
- Pharmacological characterization of GPR55, a putative cannabinoid receptor
- (2010) Haleli Sharir et al. PHARMACOLOGY & THERAPEUTICS
- The CB1 inverse agonist AM251, but not the CB1 antagonist AM4113, enhances retention of contextual fear conditioning in rats
- (2010) K.S. Sink et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Emerging strategies for exploiting cannabinoid receptor agonists as medicines
- (2009) Roger G Pertwee BRITISH JOURNAL OF PHARMACOLOGY
- Cannabinoids Δ9-Tetrahydrocannabinol and Cannabidiol Differentially Inhibit the Lipopolysaccharide-activated NF-κB and Interferon-β/STAT Proinflammatory Pathways in BV-2 Microglial Cells
- (2009) Ewa Kozela et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cannabidiol Targets Mitochondria to Regulate Intracellular Ca2+ Levels
- (2009) D. Ryan et al. JOURNAL OF NEUROSCIENCE
- Inhibitory actions of bilberry anthocyanidins on angiogenesis
- (2009) Nozomu Matsunaga et al. PHYTOTHERAPY RESEARCH
- Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
- (2009) M. G. Vander Heiden et al. SCIENCE
- Apocynin: Molecular Aptitudes
- (2008) J. Stefanska et al. MEDIATORS OF INFLAMMATION
- The orphan receptor GPR55 is a novel cannabinoid receptor
- (2007) E Ryberg et al. BRITISH JOURNAL OF PHARMACOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started